A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00164151|
Recruitment Status : Completed
First Posted : September 14, 2005
Last Update Posted : February 7, 2013
|Condition or disease||Intervention/treatment||Phase|
|Colonoscopy||Drug: HalfLytely Drug: Visicol||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||60 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||A Comparison of the Efficacy and Safety of Two Bowel Preparations: HalfLytely® (2L NuLYTELY and 20 mg Bisacodyl), and Visicol™ Prior To Colonoscopy.|
|Study Start Date :||June 2001|
|Actual Primary Completion Date :||May 2002|
- Bowel preparation success: preparation rated as "good" or "excellent" by the blinded investigator.
- Safety: review of preparation symptoms, adverse events and laboratory testing.
- Patient acceptance
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00164151
|United States, Texas|
|San Antonio, Texas, United States, 78284|
|Principal Investigator:||Charles Brady, MD||University of Texas Health Science Center San Antonio|